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As the renal stone size increases, the stone clearance rate using extracorporeal shock wave lithotripsy
(ESWL) for renal calculi decreases. For stone sizes >2 cm in diameter, the stone clearance rate of ESWL is
unsatisfactory. Thereafter, percutaneous nephrolithotomy (PCNL) is the preferred treatment of choice
because of a better stone-free rate. However, increased complications and a longer convalescence period
with PCNL became more important issues in certain cases. Previous literature reviews reported that
ureteroscopic lithotripsy (URSL) can be used as adjunct therapy in combination with PCNL. Some authors
even reported an excellent stone-free rate with minimal complications by performing URSL for large
renal calculi. Because of the availability of technologically advanced ureteroscope and improved ancillary
equipment, such as the holmium laser and ureteral access sheath, this procedure has become more
feasible and effective for treating renal calculi. In addition to reviewing stone-free and complication
rates, the literature was also reviewed for the total number of procedures carried out, and medical
expenses were compared although only a few reports are available on this subject. The contemporary
literature supports URSL as a safer, more-efﬁcient, and more cost-effective alternative to PCNL in selected
patients.
Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiwan LLC. All rights reserved.
Open access under CC BY-NC-ND license.1. Introduction
In the era of extracorporeal shock wave lithotripsy (ESWL), the
stone clearance rate for renal calculi was found to decrease as the
stone sizes increase, especially with stone sizes>2 cm in diameter.1
Therefore, ESWL is recommended only when the size of a renal
calculus is <2 cm in diameter. Percutaneous nephrolithotomy
(PCNL) is favored when the size of a renal calculus is >2 cm.
According to the American Urological Association (AUA) treatment
guidelines in 2005 and an announcement of the Taiwan Urological
Association on its website, PCNL is the ﬁrst choice of treatment for
the majority of staghorn stones that are >500 mm2 or >2.5 cm in
standardized index patients.2,3 The earlier literature reported that
ureteroscopic lithotripsy (URSL) was considered an adjunct therapy
in combination with PCNL for staghorn stones.4 Considering major
complications arising out of performing a PCNL, in addition to
technological advancements of ﬂexible ureteroscopes and ancillary
equipment, such as the holmium laser and ureteral access sheath,
ﬂexible ureteroscopy with holmium laser lithotripsy was proven toichung Hospital, 199 San-Min
ciation. Published by Elsevier Taiwbe a feasible and an effective alternative therapy with low
morbidities in selected patients, whose renal stones are not
<2 cm.5e7
From these considerations, here we present a review of the
literature with regard to stone-free rates, complications, the
number of procedures needed, and cost analysis.2. Stone-free rate and the number of procedures needed
The mean stone clearance rate for PCNL is 78% (73e84%), with
an average of 1.9 procedures per patient. The mean stone clearance
rate for PCNL with a partial staghorn stone is 74% (51e91%), while
the mean stone clearance rate for PCNL with a complete staghorn
stone is 65% (49e79%)2,8,9 which is obviously lower. Because of the
improvements in endoscopic equipment and technological
advancements in recent years, the application of PCNL for treating
renal calculi in pediatric patients was reported. Boorman et al. and
Samad et al. reported that using PCNL for treating children with
renal calculi, the original stone clearance rates were around 58%
and 59%, respectively; and cumulative stone clearance rates
increased to approximately 81e94% after adjuvant therapy. From
the literature mentioned above, the stone clearance rate of mono-
therapy with PCNL in pediatric patients is limited and adjuvant
therapies are often needed.10,11an LLC. Open access under CC BY-NC-ND license.
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combination with auxiliary equipment, such as a ureteral access
sheath, could be used as adjunctive therapy to facilitate stone
clearance during the procedure and improve the stone clearance
rate,4 while some literature demonstrated that the mean stone
clearance rate for ﬂexible ureteroscopy with holmium laser litho-
tripsy was 89.3% (approximately 85.1e93.3%) with an average of 1.5
procedures per patient (approximately 1.3e2.3 procedures per
patient) (Table 1).6,12e153. Complications
Lee et al.16 and Reddy et al.17 in early reports also pointed out
that PCNL had a higher complication rate and a longer convales-
cence period compared with ureteroscopy. Lee et al. reported that
the complication rate with PCNL was 4% in 582 patients. Major
complications included death (2/582 cases, 0.3%), bleeding that
necessitated intervention, urinary tract injuries (urinoma forma-
tion, renal pelvic lacerations, ureteral avulsion, and ureteropelvic or
ureteral stricture), and injuries to adjacent organs (pneumothorax,
hemothorax, and bowel injury).16 The AUA guidelines in 2005 re-
ported that the complication rate for PCNL was about 15%
(approximately 7e27%) with acute complication rates of around 5%
and mortality rates of around 2% (four deaths in 210 cases).2
Boorman et al. and Samad et al. reported that major complication
rates of PCNL when treating children with renal calculi were 9%
(one blood transfusion and one urosepsis among 23 patients) and
4% (seven blood transfusions among 169 patients).10,11
From a review of the literature in Table 1, the complication rate
for ureteroscopic management of renal calculi >2 cm was 11.6%
(5.8e18.2%) (18 of 155 cases). Therewas only 1 case of the 155 cases
analyzed, <1%, that experienced a cerebral vascular accident post-
operatively.6,12e15 No deaths were reported.
As a result of instrument improvements, miniaturization of
ureteroscopes and ancillary devices, and the introduction of the
holmium laser, indications for ureteroscopy are evolving. Tan et al.
reported a 95% stone-free rate without surgical complications in
ureteroscopic management of pediatric renal calculi.18 Watterson
et al. reported an 89% overall stone-free rate without obstetric or
urologic complications for symptomatic calculi in pregnant patients
for whom conservative therapy had failed.19 In morbidly obese
patients who suffer from urolithiasis, there are limited treatment
options. ESWL and PCNL may be difﬁcult in these patients, and
ureteroscopy is an alternative procedure of choice with minimal
invasiveness. Dash et al. reported that ureteroscopic treatment of
renal calculi is a safe and effective ﬁrst-line treatment for renal
calculi in morbidly obese patients with an overall success rate of
83%.20 Wheat et al. reported that planned multisession retrograde
endoscopic lithotripsy (REL) is a safe alternative to PCNL in
morbidly obese patients, who suffer from renal stones >2.0 cm in
diameter, which cause difﬁculties with implementing PCNL.21
Although the stone-free rate after ﬁnal treatment is expected toTable 1
Review of the literature on ureteroscopic management of renal calculi >2 cm in
diameter.
Reference No. of
patients
Stone-free
rate (%)
Complications
(%)
No. of
procedures
Mariani 200413 16 92 6.3 1.5
Grasso et al. 199812 51 91 5.8 1.3
Breda et al. 20086 15 93.3 20 2.3
Breda et al. 200914 51 85.1 13.6 1.4
Riley et al. 200915 22 90.9 18.2 1.8
155 89.3 11.6 1.5be low, it was actually 33%, because of the complexity of cases,
while there were no intraoperative complications with multi-
session REL. Riley et al. reported similar planned multisession
ureteroscopywith holmium laser lithotripsy for patients with stone
diameters >2.5 cm as an alternative treatment option to PCNL. The
overall stone-free rate was 90.9%. The complication rate was 18.2%,
and no major complications were reported.15
Turna et al. reported a retrospectively matched cohort study
which indicated that ﬂexible ureteroscopy with holmium laser
lithotripsy is safe and effective for renal calculi in patients on
anticoagulant therapy. It does not require perioperative manipu-
lation, because it neither increases the risk of bleeding nor reduces
the stone-free rate in the anticoagulant group.224. Cost analysis
Because the national health insurance policy in Taiwan uses
a global budget to control total health-care expenses, the cost of
disease treatment also needs to be taken into consideration. A
retrospective study reported that the cost for PCNLwas signiﬁcantly
higher than that of ﬂexible ureteroscopy with holmium laser litho-
tripsy.23 Becauseonly limited reports are available regarding the cost
of treatment in this ﬁeld, the author tried to analyze the estimated
costs of similar cases in our hospital. The cost of PCNLwas estimated
to be NT$57,102 (NT$ ¼ New Taiwan dollar; in 2011, the estimated
average exchange ratewasUS$1.00zNT$30.00)with ahospital stay
of 8 days, while the cost of ﬂexible URSL with holmium laser litho-
tripsy was estimated to be NT$36,708 with a hospital stay of 4 days.
This result is similar to the report above,which found that the cost of
PCNLwas signiﬁcantly higher than that ofﬂexible ureteroscopywith
holmium laser lithotripsy. The hospital stay was also signiﬁcantly
shorter for ﬂexible ureteroscopy, and this might be attributed to its
less invasiveness and minimal complications.5. Conclusions
With evolving techniques and advancements in instrumenta-
tion, indications for ureteroscopic treatment of renal calculi are
increasing because of excellent stone-free rates and minimal major
complications.24,25 In considering the overall risks and major
complications of PCNL, ureteroscopy with holmium laser litho-
tripsy and REL is a safe and efﬁcient alternative to PCNL in selective
patients, even in those with renal stones >2.0 cm in diameter.Conﬂicts of interest statement
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